Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

EMQN best practice guidelines for the molecular genetic testing and reporting of chromosome 11p15 imprinting disorders: Silver-Russell and Beckwith-Wiedemann syndrome

Research output: Contribution to journalJournal articleResearchpeer-review


  1. Haploinsufficiency of ARHGAP42 is associated with hypertension

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Correction: Educational delay and attainment in persons with neurofibromatosis 1 in Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. The Global State of the Genetic Counseling Profession

    Research output: Contribution to journalReviewResearchpeer-review

  1. Development, behaviour and autism in individuals with SMC1A variants

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Mosaic MECP2 variants in males with classical Rett syndrome features, including stereotypical hand movements

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Katja Eggermann
  • Jet Bliek
  • Frédéric Brioude
  • Elizabeth Algar
  • Karin Buiting
  • Silvia Russo
  • Zeynep Tümer
  • David Monk
  • Gudrun Moore
  • Thalia Antoniadi
  • Fiona Macdonald
  • Irène Netchine
  • Paolo Lombardi
  • Lukas Soellner
  • Matthias Begemann
  • Dirk Prawitt
  • Eamonn R Maher
  • Marcel Mannens
  • Andrea Riccio
  • Rosanna Weksberg
  • Pablo Lapunzina
  • Karen Grønskov
  • Deborah Jg Mackay
  • Thomas Eggermann
View graph of relations

Molecular genetic testing for the 11p15-associated imprinting disorders Silver-Russell and Beckwith-Wiedemann syndrome (SRS, BWS) is challenging because of the molecular heterogeneity and complexity of the affected imprinted regions. With the growing knowledge on the molecular basis of these disorders and the demand for molecular testing, it turned out that there is an urgent need for a standardized molecular diagnostic testing and reporting strategy. Based on the results from the first external pilot quality assessment schemes organized by the European Molecular Quality Network (EMQN) in 2014 and in context with activities of the European Network of Imprinting Disorders ( towards a consensus in diagnostics and management of SRS and BWS, best practice guidelines have now been developed. Members of institutions working in the field of SRS and BWS diagnostics were invited to comment, and in the light of their feedback amendments were made. The final document was ratified in the course of an EMQN best practice guideline meeting and is in accordance with the general SRS and BWS consensus guidelines, which are in preparation. These guidelines are based on the knowledge acquired from peer-reviewed and published data, as well as observations of the authors in their practice. However, these guidelines can only provide a snapshot of current knowledge at the time of manuscript submission and readers are advised to keep up with the literature.European Journal of Human Genetics advance online publication, 11 May 2016; doi:10.1038/ejhg.2016.45.

Original languageEnglish
JournalEuropean journal of human genetics : EJHG
Pages (from-to)1377–1387
Publication statusPublished - 11 May 2016

ID: 46437614